Top Markets
#1 GEKKO GEKKO +52.86%
#2 Helium Helium +51.20%
#3 Siren Siren +26.90%
#4 Pons Pons +22.87%
#5 Main Street Yield Main Street Yield +17.48%
#6 龙虾 (Lobster) 龙虾 (Lobster) +15.82%
#7 Nillion Nillion +14.76%
#8 Collect on Fanable Collect on Fanable +14.29%
#9 Cysic Cysic +13.45%
#10 o1.exchange o1.exchange +13.41%
Coin of the day
GEKKO GEKKO
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Kolon TissueGene, Inc. Kolon TissueGene, Inc.

Kolon TissueGene, Inc.

950160
Rang in Aktien #9085
Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the... Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the advancement of clinical-stage cell-based treatments for osteoarthritis. Its flagship offering is TG-C, a proprietary platform technology that integrates allogeneic primary cells with genetically engineered counterparts. Established by Kwan H. Lee on June 9, 1999, the enterprise maintains its corporate headquarters in Rockville, Maryland.
Aktienkurs
$12.94
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$1.10B
Veränderung (1 Tag)
-0.16%
Veränderung (1 Jahr)
-51.50%
Land
US
Handel Kolon TissueGene, Inc. (950160)

Kategorie

Healthcare
Kursverlauf für Kolon TissueGene, Inc. (950160)
Höchster Schlusskurs: $14.96 am 2026-08-01

Niedrigster Schlusskurs: $50.89 am 2017-11-01
Kursverlauf der Aktie von Kolon TissueGene, Inc. von 2017 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -2.28%
2025 232.88%
2024 144.93%
2023 -18.79%
2022 -12.44%
2019 -73.89%
2018 -22.36%
2017 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH